CCL17 and Alzheimer disease: Among these markers, CCL17 was the one showing the highest correlation with AD severity, although its levels are generally variable with AD heterogeneity and underlying inflammatory pathways (Landheer et al., 2014; Thijs J. L. et al., 2015).